Harvard Bioscience Stock Volatility
| HBIO Stock | USD 0.64 0.01 0.85% |
Harvard Bioscience appears to be abnormally volatile, given 3 months investment horizon. Harvard Bioscience holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12 % return per unit of risk over the last 3 months. By evaluating Harvard Bioscience's technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please utilize Harvard Bioscience's Market Risk Adjusted Performance of 0.4818, downside deviation of 5.78, and Risk Adjusted Performance of 0.0925 to validate if our risk estimates are consistent with your expectations.
Sharpe Ratio = 0.1241
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | HBIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Harvard Bioscience is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harvard Bioscience by adding it to a well-diversified portfolio.
Key indicators related to Harvard Bioscience's volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Harvard Bioscience Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Harvard daily returns, and it is calculated using variance and standard deviation. We also use Harvard's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Harvard Bioscience volatility.
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Harvard Bioscience can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Harvard Bioscience at lower prices. For example, an investor can purchase Harvard stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Harvard Bioscience's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns. Main indicators related to Harvard Bioscience's market risk premium analysis include:
Beta 1.78 | Alpha 0.71 | Risk 7.75 | Sharpe Ratio 0.12 | Expected Return 0.96 |
Moving together with Harvard Stock
| 0.65 | TMO | Thermo Fisher Scientific | PairCorr |
| 0.73 | NMIH | NMI Holdings | PairCorr |
| 0.75 | ATI | Allegheny Technologies | PairCorr |
| 0.69 | SANM | Sanmina | PairCorr |
| 0.87 | FYBR | Frontier Communications Sell-off Trend | PairCorr |
| 0.66 | ACN | Accenture plc | PairCorr |
| 0.82 | WSFS | WSFS Financial | PairCorr |
| 0.71 | F | Ford Motor Aggressive Push | PairCorr |
| 0.7 | DQ | Daqo New Energy | PairCorr |
| 0.77 | ACR-PC | ACRES Commercial Realty | PairCorr |
| 0.8 | BOF | BranchOut Food Common | PairCorr |
Moving against Harvard Stock
| 0.81 | PRTC | PureTech Health plc | PairCorr |
| 0.68 | JAKK | JAKKS Pacific | PairCorr |
| 0.48 | VLCN | VLCN Old Symbol Change | PairCorr |
| 0.44 | PSGTF | PT Semen Indonesia | PairCorr |
| 0.33 | NVR | NVR Inc | PairCorr |
Harvard Bioscience Market Sensitivity And Downside Risk
Harvard Bioscience's beta coefficient measures the volatility of Harvard stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Harvard stock's returns against your selected market. In other words, Harvard Bioscience's beta of 1.78 provides an investor with an approximation of how much risk Harvard Bioscience stock can potentially add to one of your existing portfolios. Harvard Bioscience is displaying above-average volatility over the selected time horizon. Harvard Bioscience is a potential penny stock. Although Harvard Bioscience may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Harvard Bioscience. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Harvard instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Harvard Bioscience Demand TrendCheck current 90 days Harvard Bioscience correlation with market (Dow Jones Industrial)Harvard Bioscience Volatility and Downside Risk
Harvard standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Using Harvard Put Option to Manage Risk
Put options written on Harvard Bioscience grant holders of the option the right to sell a specified amount of Harvard Bioscience at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Harvard Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Harvard Bioscience's position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Harvard Bioscience will be realized, the loss incurred will be offset by the profits made with the option trade.
Harvard Bioscience's PUT expiring on 2026-02-20
Profit |
| Harvard Bioscience Price At Expiration |
Current Harvard Bioscience Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | HBIO260220P00000500 | -0.213293 | 0.915568 | 9 | 2026-02-20 | 0.0 - 0.05 | 0.0 | View |
Put | HBIO260220P00001000 | -0.947356 | 0.674476 | 3 | 2026-02-20 | 0.15 - 0.55 | 0.0 | View |
Put | HBIO260220P00002000 | -0.843786 | 0.465065 | 2 | 2026-02-20 | 1.15 - 1.6 | 0.0 | View |
Harvard Bioscience Stock Volatility Analysis
Volatility refers to the frequency at which Harvard Bioscience stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Harvard Bioscience's price changes. Investors will then calculate the volatility of Harvard Bioscience's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Harvard Bioscience's volatility:
Historical Volatility
This type of stock volatility measures Harvard Bioscience's fluctuations based on previous trends. It's commonly used to predict Harvard Bioscience's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Harvard Bioscience's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Harvard Bioscience's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Harvard Bioscience Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Harvard Bioscience Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.7751 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Harvard Bioscience will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Harvard Bioscience or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Harvard Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Harvard stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Harvard Bioscience has an alpha of 0.7063, implying that it can generate a 0.71 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Harvard Bioscience Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Harvard Bioscience Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Harvard Bioscience is 805.93. The daily returns are distributed with a variance of 60.1 and standard deviation of 7.75. The mean deviation of Harvard Bioscience is currently at 4.96. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.74
α | Alpha over Dow Jones | 0.71 | |
β | Beta against Dow Jones | 1.78 | |
σ | Overall volatility | 7.75 | |
Ir | Information ratio | 0.10 |
Harvard Bioscience Stock Return Volatility
Harvard Bioscience historical daily return volatility represents how much of Harvard Bioscience stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 7.7523% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7071% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Harvard Stock performing well and Harvard Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Harvard Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NXGL | 4.15 | (0.63) | 0.00 | (0.17) | 0.00 | 12.42 | 35.89 | |||
| RVP | 2.09 | (0.23) | 0.00 | (0.21) | 0.00 | 6.52 | 19.50 | |||
| FEMY | 7.20 | (0.21) | 0.00 | (0.04) | 0.00 | 15.00 | 50.65 | |||
| NXL | 6.57 | (0.02) | 0.03 | 0.07 | 6.76 | 12.40 | 117.23 | |||
| SONN | 10.16 | (0.30) | 0.00 | (0.33) | 0.00 | 19.48 | 69.59 | |||
| TAOX | 6.90 | (0.57) | 0.00 | (0.02) | 0.00 | 16.49 | 58.25 | |||
| NCNA | 4.38 | (0.46) | 0.00 | (0.15) | 0.00 | 8.09 | 54.00 | |||
| COSM | 4.15 | (0.95) | 0.00 | (0.72) | 0.00 | 8.16 | 27.74 | |||
| CLGN | 3.31 | (0.77) | 0.00 | (0.54) | 0.00 | 5.71 | 20.81 |
About Harvard Bioscience Volatility
Volatility is a rate at which the price of Harvard Bioscience or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Harvard Bioscience may increase or decrease. In other words, similar to Harvard's beta indicator, it measures the risk of Harvard Bioscience and helps estimate the fluctuations that may happen in a short period of time. So if prices of Harvard Bioscience fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 20 M | 19 M | |
| Market Cap | 204.3 M | 214.5 M |
Harvard Bioscience's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Harvard Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Harvard Bioscience's price varies over time.
3 ways to utilize Harvard Bioscience's volatility to invest better
Higher Harvard Bioscience's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Harvard Bioscience stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Harvard Bioscience stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Harvard Bioscience investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Harvard Bioscience's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Harvard Bioscience's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Harvard Bioscience Investment Opportunity
Harvard Bioscience has a volatility of 7.75 and is 10.92 times more volatile than Dow Jones Industrial. 69 percent of all equities and portfolios are less risky than Harvard Bioscience. You can use Harvard Bioscience to protect your portfolios against small market fluctuations. The stock experiences a moderate downward daily trend and can be a good diversifier. Check odds of Harvard Bioscience to be traded at $0.6316 in 90 days.Average diversification
The correlation between Harvard Bioscience and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Harvard Bioscience and DJI in the same portfolio, assuming nothing else is changed.
Harvard Bioscience Additional Risk Indicators
The analysis of Harvard Bioscience's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Harvard Bioscience's investment and either accepting that risk or mitigating it. Along with some common measures of Harvard Bioscience stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0925 | |||
| Market Risk Adjusted Performance | 0.4818 | |||
| Mean Deviation | 4.75 | |||
| Semi Deviation | 4.53 | |||
| Downside Deviation | 5.78 | |||
| Coefficient Of Variation | 889.68 | |||
| Standard Deviation | 7.54 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Harvard Bioscience Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Harvard Bioscience as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Harvard Bioscience's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Harvard Bioscience's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Harvard Bioscience.
When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (1.21) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.